The most common side effects found in Wegovy clinical trials were gastrointestinal, including nausea, vomiting, diarrhea, constipation and abdominal pain, said both Ur and Wharton

Research indicates it can: Increase collagen production in damaged tissues Improve tendon-to-bone healing Enhance muscle fiber regeneration Reduce recovery time from sprains, strains, and tears Digestive System Repair Perhaps its most well-documented benefit is gut healing, with potential applications for: Inflammatory bowel conditions like Crohns disease and ulcerative colitis Leaky gut syndrome Gastric ulcers Acid reflux and GERD General gut inflammation Neuroprotective Effects Emerging research suggests BPC-157 may offer protection for the nervous system by: Promoting nerve regeneration after injury Potentially improving cognitive function Showing promise for conditions involving nerve damage Anti-Inflammatory Properties BPC-157 helps modulate the bodys inflammatory response, making it valuable for both acute injuries and chronic inflammatory conditions

Several clinical trials are investigating whether GLP-1 receptor agonists can slow cognitive decline in patients with mild cognitive impairment or early Alzheimer's disease, including studies with semaglutide (EVOKE and EVOKE+ trials)
Disclaimer: This blog post is for informational purposes only and should not be construed as medical advice
Eli Lilly's TRIUMPH trials describe once-weekly subcutaneous injection